Th17细胞及其在相关肝病中的作用

杨波; 赵彩彦

Th17细胞及其在相关肝病中的作用

杨波,
赵彩彦

河北医科大学第三医院感染科

详细信息

中图分类号: R575
计量
- 文章访问数: 3302
- HTML全文浏览量: 21
- PDF下载量: 1242
- 被引次数: 0
出版历程
- 出版日期: 2011-02-20

Advanced research on Th17 cell and its relevant role in the progress liver diseases

摘要

摘要: Th17细胞是一种不同于Th1细胞和Th2细胞的新型CD4+T细胞亚群。Th17细胞分化需要转化生长因子β和白细胞介素（IL）-6、转录因子孤儿核受体（ROR）γt等参与,分泌IL-17A、IL-17F、IL-21、IL-22、IL-6、肿瘤坏死因子（TNF）α等多种细胞因子,参与自身免疫性肝病、急性肝损伤、慢性乙型肝炎、乙型肝炎肝纤维化、肝癌和肝移植术后急性排斥反应的发生发展。本文旨在对Th17细胞与肝脏疾病的研究进展作一综述。
- T淋巴细胞 /
- 辅助诱导 /
- 肝疾病
Abstract: Th17 cell is a new CD4+ T cell subset which is different from Th1 cell and Th2 cell.The differentiation of Th17 cell requires the participation of transforming growth factor β and interleukin 6, and transcription factor orphan nuclear hormone receptor-γt.It produces many cytokines, such as IL-17A, IL-17F, IL-21, IL-22, IL-6, TNFα, and takes part in the genesis and development of autoimmune liver diseases, acute hepatic injury, chronic hepatitis B, hepatitis B related liver fibrosis, hepatocellular carcinoma and acute rejection in liver transplantation.In this review, we summarized the progressed studies on Th17 cells and liver diseases.
- T-lymphocytes /
- helper-inducer /
- liver diseases

HTML全文

参考文献(30)

[1]Veldhoen M, Hocking RJ, Atkins CJ, et al.TGFbeta inthe context of an inflammatory cytokine milieu supportsde novo differentiation of IL-17-producing T cells[J].Immunity, 2006, 24 (2) :179-189.

[2]Bettelli E, Carrier Y, Gao W, et al.Reciprocaldevelopmental pathways for the generation ofpathogenic effector TH17 and regulatory T cells[J].Nature, 2006, 441 (7090) :235-238.

[3]Mangan PR, Harrington LE, O'Quinn DB, et al.Transfor-ming growth factor-beta induces development of theT (H) 17 lineage[J].Nature, 2006, 441 (7090) :231-234.

[4]Yang XO, Panopoulos AD, Nurieva R, et al.STAT3 regulatescytokine-mediated generation of inflammatory helper Tcells[J].J Biol Chem, 2007, 282 (13) :9358-9363.

[5]Nurieva R, Yang XO, Martine G, et al.Essential autocrineregulation by IL-21 in the generation of inflammation Tcells[J].Nature, 2007, 448 (7152) :480-483.

[6]Langrish CL, Chen Y, Blumenschein WM, et al.IL-23 drives a pathogenic T cell population that inducesautoimmune inflammation[J].J Exp Med, 2005, 201 (2) :233-240.

[7]Ivanov II, McKenzie BS, Zhou L, et al.The orphan nuclearreceptor RORgammat directs the differentiation programof proinflammatory IL-17+T helper cells[J].Cell, 2006, 126 (6) :1121-1133.

[8]Yang XO, Pappu BP, Nurieva R, et al.T helper 17lineage differentiation is programmed by orphan nuclearreceptors ROR alpha and ROR gamma[J].Immunity, 2008, 28 (1) :29-39.

[9]Brustle A, Heink S, Huber M, et al.The development ofinflammatory T (H) -17 cells requires interferon-regulatoryfactor 4[J].Nat Immunol, 2007, 8 (9) :958-966.

[10]Harrington LE, Hatton RD, Mangan PR, et al.Interleukin17-producing CD4+effect T cells develop via a lineagedistinct from the T helper type 1 and 2 lineages[J].NatImmunol, 2005, 6 (11) :1123-1132.

[11]Kolls JK, Linden A.Interleukin-17 family members andinflammation[J].Immunity, 2004, 21 (4) :467-476.

[12]Zrioual S, Toh ML, Tournadre A, et al.IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+CXC chemokine expression in synoviocytes and areoverexpressed in rheumatoid blood[J].J Immunol, 2008, 180 (1) :655-663.

[13]Yang XO, Chang SH, Pak H, et al.Regulation ofinflammatory responses by IL-17F[J].J Exp Med, 2008, 205 (5) :1063-1075.

[14]Lan RY, Salunqa TL, Tsuneyama K, et al.Hepatic IL-17 responses in human and murine primary biliarycirrhosis[J].J Autoimmun, 2009, 32 (1) :43-51.

[15]Harada K, Shimoda S, Sato Y, et al.Periductal interleukin-17 production in association with biliary innate immunitycontributes to the pathogenesis of cholangiopathy inprimary biliary cirrhosis[J].Clin Exp Immunol, 2009, 157 (2) :261-270.

[16]Rong G, Zhou Y, Xiong Y, et al.Imbalance between Thelper type 17 and T regulatory cells in patients withprimary biliary cirrhosis:the serum cytokine profile andperipheral cell population[J].Clin Exp Immunol, 2009, 156 (2) :217-225.

[17]Yasumi Y, Takikawa Y, Endo R, et al.Interleukin-17 as anew marker of severity of acute hepatic injury[J].HepatolRes, 2007, 37 (4) :248-254.

[18]Lauren A, Zenewicz, George D, et al.IL-22 but not IL-17 provides protection to hepatocytes during acute liverinflammation[J].Immunity, 2007, 27 (4) :647-659.

[19]Hou W, Kang HS, Kim BS, et al.Th17 cells enhance viralpersistence and inhibit T cell cytotoxicity in a model of chronicvirus infection[J].J Exp Med, 2009, 206 (2) :313-328.

[20]Ge J, Wang K, Meng QH, et al.Implication of Th17 andTh1 cells in patients with chronic active hepatitis B[J].JClin Immunol, 2010, 30 (1) :60-67.

[21]Zhang JY, Zhang Z, Lin F, et al.Interleukin-17-producingCD4 (+) T cells increase with severity of liver damage inpatients with chronic hepatitis B[J].Hepatology, 2010, 51 (1) :81-91.

[22]Szabo G, Mandrekar P, Dolganiuc A, et al.Innate immuneresponse and hepatic inflammation[J].Semin Liver Dis, 2007, 27 (4) :339-350.

[23]Wu W, Li J, Chen F, et al.Circulating Th17 cells frequen-cy is associated with the disease progression in HBVinfected patients[J].J Gastroenterol Hepatol, 2010, 25 (4) :750-757.

[24]邢直直, 杜文军, 陈士俊.辅助性T淋巴细胞1、2、17在慢性乙型肝炎病毒感染状态中的变化[J].中华传染病杂志, 2008, 26 (3) :158-162.

[25]Xu Y, Du WJ, Qin LY, et al.Expression of interleukin-17in hepatitis B related liver fibrosis[J].Xi Bao Yu Fen ZiMian Yi Xue Za Zhi, 2009, 25 (2) :133-135.

[26]Wang L, Yi T, Kortylewski M, et al.IL-17 can promotetumor growth through an IL-6-Stat3 signalingpathway[J].J Exp Med, 2009, 206 (7) :1457-1464.

[27]Kuang DM, Peng C, Zhao Q, et al.Activated monocytesin peritumoral stroma of hepatocellular carcinomapromote expansion of memory T helper 17 Cells[J].Hepatology, 2010, 51 (1) :154-164.

[28]Zhang JP, Yan J, Xu J, et al.Increased intratumoralIL-17-producing cells correlate with poor survival inhepatocellular carcinoma patients[J].J Hepatol, 2009, 50 (5) :980-989.

[29]Fabrega E, Lopez-Hoyos M, San Segundo D.Changes inthe serum levels of interleukin-17/Interleukin-23 duringacute rejection in liver transplantation[J].Liver Transpl, 2009, 15 (6) :629-633.

[30]Fabrega E, Lopez-Hoyos M, San Segundo D.Effect ofimmunosuppressant blood levels on serum concentrationof interleukin-17 and-23 in stable liver transplantrecipients[J].Transplant Proc, 2009, 41 (3) :1025-1027.

施引文献

资源附件(0)

访问统计